» Articles » PMID: 39132649

Distinct Molecular Profiles of Sporadic Early-Onset Colorectal Cancer: A Population-Based Cohort and Systematic Review

Overview
Journal Gastro Hep Adv
Specialty Gastroenterology
Date 2024 Aug 12
PMID 39132649
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: The observed increase in the incidence of early-onset colorectal cancer (EOCRC) is being driven by sporadic cases, but the molecular characteristics of these tumors are not fully understood. Our objective was to investigate the prevalence of microsatellite instability (MSI) and selected mutations in sporadic EOCRC, and their association with survival.

Methods: Firstly, we compared the prevalence of molecular characteristics and survival within a population-based cohort study of 652 stage II and III colon cancer patients in Northern Ireland, comparing sporadic early-onset (<50 years, n = 35) with older (60-69 years, n = 179) patients. Secondly, a systematic review for studies reporting the prevalence of MSI, mismatch repair deficiency (dMMR), or , , , , and mutations in sporadic EOCRC was conducted. A meta-analysis was performed to calculate pooled estimates of the prevalence of molecular features in sporadic EOCRC.

Results: Firstly, within the cohort study, EOCRC patients did not have a significantly increased risk of colorectal cancer-specific death (adjusted hazard ratio 1.20; 95% confidence interval [CI] 0.61-2.39) compared with 60- to 69-year-olds. Second, 32 studies were included in the systematic review. The pooled analysis estimated a prevalence of 10% (95% CI 7%-14%) for MSI high/dMMR in sporadic EOCRC. and mutations had a prevalence of 1% (95% CI 0%-3%) and 32% (95% CI 23%-40%), respectively.

Conclusion: The molecular characteristics of sporadic EOCRC differ from those of cancers in older adults, particularly regarding reduced prevalence of mutations. Ten percent of sporadic EOCRC display MSI high/dMMR. Further studies are needed to address survival in sporadic EOCRC cases and whether molecular profiles influence EOCRC outcomes in this patient group.

Citing Articles

Decoding early-onset of colorectal cancer: Insights into SERPINA3 expression patterns.

Soman A, Pradhan T, Krishna R, Hermon E, Somanathan T, George J Heliyon. 2024; 10(22):e40119.

PMID: 39584126 PMC: 11585722. DOI: 10.1016/j.heliyon.2024.e40119.


A decade-long study on pathological distinctions of resectable early versus late onset colorectal cancer and optimal screening age determination.

Song J, Han T, Qian L, Zhu J, Qiao Y, Liu S Sci Rep. 2024; 14(1):27335.

PMID: 39521798 PMC: 11550830. DOI: 10.1038/s41598-024-76951-4.


Early Onset Colorectal Cancer: Molecular Underpinnings Accelerating Occurrence.

Zinkeng A, Taylor F, Cheong S, Song H, Merchant J Cell Mol Gastroenterol Hepatol. 2024; 19(2):101425.

PMID: 39510499 PMC: 11731505. DOI: 10.1016/j.jcmgh.2024.101425.


Survival Analysis, Clinical Characteristics, and Predictors of Cerebral Metastases in Patients with Colorectal Cancer.

Jeri-Yabar A, Vittini-Hernandez L, Benites-Meza J, Prado-Nunez S Med Sci (Basel). 2024; 12(3).

PMID: 39311160 PMC: 11417931. DOI: 10.3390/medsci12030047.


Advances in Precision Medicine Approaches for Colorectal Cancer: From Molecular Profiling to Targeted Therapies.

Kiran N, Yashaswini C, Maheshwari R, Bhattacharya S, Prajapati B ACS Pharmacol Transl Sci. 2024; 7(4):967-990.

PMID: 38633600 PMC: 11019743. DOI: 10.1021/acsptsci.4c00008.

References
1.
Pilozzi E, Maresca C, Duranti E, Giustiniani M, Catalanotto C, Lucarelli M . Left-sided early-onset vs late-onset colorectal carcinoma: histologic, clinical, and molecular differences. Am J Clin Pathol. 2015; 143(3):374-84. DOI: 10.1309/AJCPNOC55IOLXFUD. View

2.
Suzuki O, Eguchi H, Chika N, Sakimoto T, Ishibashi K, Kumamoto K . Prevalence and clinicopathologic/molecular characteristics of mismatch repair-deficient colorectal cancer in the under-50-year-old Japanese population. Surg Today. 2017; 47(9):1135-1146. DOI: 10.1007/s00595-017-1486-x. View

3.
Kim H, Kim C, Yu C, Roh S, Kim J . Methylation of the hMLH1 and hMSH2 promoter in early-onset sporadic colorectal carcinomas with microsatellite instability. Int J Colorectal Dis. 2003; 18(3):196-202. DOI: 10.1007/s00384-002-0445-0. View

4.
Mork M, You Y, Ying J, Bannon S, Lynch P, Rodriguez-Bigas M . High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer. J Clin Oncol. 2015; 33(31):3544-9. PMC: 4979241. DOI: 10.1200/JCO.2015.61.4503. View

5.
Bateman A . DNA mismatch repair proteins: scientific update and practical guide. J Clin Pathol. 2021; 74(4):264-268. DOI: 10.1136/jclinpath-2020-207281. View